Funding round brings in $18M for inflammatory drug developer

04/8/2013 | MedCityNews.com

Aquinox Pharmaceuticals, which develops small-molecule therapies for inflammatory disorders, raised $18 million in a Series C funding round from investors including Pfizer and Johnson & Johnson's venture units. The firm says midstage trials of AQX-1125, its lead drug candidate, could begin within months in patients with chronic obstructive pulmonary disease and interstitial cystitis.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC